239 related articles for article (PubMed ID: 35874989)
1. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
Front Public Health; 2022; 10():898270. PubMed ID: 35874989
[TBL] [Abstract][Full Text] [Related]
2. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
Mao C; Gao Y; Wan M; Xu N
Funct Integr Genomics; 2022 Aug; 22(4):597-609. PubMed ID: 35420332
[TBL] [Abstract][Full Text] [Related]
3. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
4. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
Fan Z; Wang Y; Niu R
Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.
Ho KH; Huang TW; Shih CM; Lee YT; Liu AJ; Chen PH; Chen KC
BMC Med; 2021 Feb; 19(1):59. PubMed ID: 33627136
[TBL] [Abstract][Full Text] [Related]
6. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping.
Liang H; Zhao Y; Liu K; Xiao Y; Chen K; Li D; Zhong S; Zhao Z; Wu D; Peng Y
Front Genet; 2022; 13():997739. PubMed ID: 36467998
[TBL] [Abstract][Full Text] [Related]
8. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
9. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
Ho KH; Shih CM; Liu AJ; Chen KC
Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
[TBL] [Abstract][Full Text] [Related]
11. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
12. Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma.
Yang X; Niu S; Liu J; Fang J; Wu Z; Ling S; Di G; Jiang X
Sci Rep; 2021 Dec; 11(1):23694. PubMed ID: 34880375
[TBL] [Abstract][Full Text] [Related]
13. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
[TBL] [Abstract][Full Text] [Related]
14. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment.
Fu R; Hong X
Biomed Res Int; 2022; 2022():3113857. PubMed ID: 35528175
[TBL] [Abstract][Full Text] [Related]
15. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
16. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z
Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987
[TBL] [Abstract][Full Text] [Related]
17. Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma.
Long S; Wu B; Yang L; Wang L; Wang B; Yan Y; Jiang J; Yang B; Zhou Q; Shi M; Liang W; Wei W; Li X
Front Neurol; 2023; 14():1054686. PubMed ID: 37153654
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
20. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
Li Q; Yu Q; Ji J; Wang P; Li D
Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
